Cargando…
Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review
BACKGROUND: Clinical trial reports often emphasize efficacy over harms, leading to misinterpretation of the risk‐to‐benefit ratio of new therapies. Clear and sufficiently detailed reporting of methods and results is especially important in the abstracts of trial reports, as readers often base their...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367648/ https://www.ncbi.nlm.nih.gov/pubmed/32452660 http://dx.doi.org/10.1002/cam4.3095 |